Skip to content

The diagnosis for early ovarian cancer from the detection of AMH, D-dimer combined with serum CA125 and HE4.

The diagnosis for early ovarian cancer from the detection of AMH, D-dimer combined with serum CA125 and HE4.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122128
Enrollment
Unknown
Registered
2026-04-09
Start date
2026-04-09
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign ovarian tumo and ovarian cancer

Interventions

Ovarian benign tumor group:None
Healthy control group:None

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Patient is treatment-naive and does not receive any prior surgical treatment or adjuvant therapies such as radiotherapy or chemotherapy. 2.Patient has been pathologically diagnosed with ovarian benign or malignant tumor following surgical treatment. 3.Complete clinical case data; 4.Patient does not have other malignant tumors. 5.Patient has not get chronic infections, hematological disorders, or autoimmune diseases recently.

Exclusion criteria

Exclusion criteria: 1.Patient get inflammatory or infectious diseases and has recently received anti-infective treatment concurrently; 2.Patient get other primary malignant tumors concurrently. 3.Patient received anti-tumor treatment before surgery. 4.Patient is in pregnancy or lactation period. 5.Patient who severes hepatic or renal diseases, bone marrow or blood disorders, and autoimmune diseases that affect blood cell counts; 6.Patient who takies oral medications that affect platelet function, coagulation, or hemostasis.

Design outcomes

Primary

MeasureTime frame
HE4;CA125;Serum AMH;D-dimer;

Countries

China

Contacts

Public ContactWeijuan Chen

Yuebei People’s Hospital

987376103@qq.com+86 751 6913 3343

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026